Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
Public ClinicalTrials.gov record NCT01119105. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Multi-center, Randomized, Double-blind Study Comparing the Safety and Efficacy of Two Doses of BC-3781 Versus Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection
Study identification
- NCT ID
- NCT01119105
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Nabriva Therapeutics AG
- Industry
- Enrollment
- 210 participants
Conditions and interventions
Conditions
Interventions
- BC-3781 Drug
- Vancomycin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2010
- Primary completion
- Dec 30, 2010
- Completion
- Feb 2, 2011
- Last update posted
- Nov 16, 2020
2010 – 2011
United States locations
- U.S. sites
- 9
- U.S. states
- 5
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| BC-3781 Study Center 002 | Chula Vista | California | 91911 | — |
| BC-3781 Study Center 001 | La Mesa | California | 91942 | — |
| BC-3781 Study Center 003 | Oceanside | California | 92056 | — |
| BC-3781 Study Center 012 | Columbus | Georgia | 31904 | — |
| BC-3781 Study Center 018 | Savannah | Georgia | 31406 | — |
| BC-3781 Study Center 021 | Baton Rouge | Louisiana | 70808 | — |
| BC-3781 Study Center 023 | Lafayette | Louisiana | 70503 | — |
| BC-3781 Study Center 004 | Butte | Montana | 59701 | — |
| BC-3781 Study Center 016 | Somers Point | New Jersey | 08244 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01119105, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 16, 2020 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01119105 live on ClinicalTrials.gov.